AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Dec 22, 2015

34983_dirs_2015-12-21_71b8c864-ca60-405e-a55b-a28a8fae31d0.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-18	Common Shares	P	15000	$0.2098	Acquired	6894314	Direct
2015-12-18	Common Shares	P	5000	$0.26	Acquired	6899314	Direct
2015-12-18	Common Shares	P	2500	$0.2	Acquired	6901814	Direct
2015-12-21	Common Shares	P	1000	$0.25	Acquired	6902814	Direct
2015-12-21	Common Shares	P	2500	$0.2	Acquired	6905314	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4937854	Indirect
Common Shares	6879314	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.1	2019-12-23	Common Shares (550000)	550000	Direct
Stock Options	$0.32	2016-07-11	Common Shares (220000)	770000	Direct
Stock Options	$0.09	2018-06-18	Common Shares (247500)	1017500	Direct
Warrants	$0.23	2017-05-15	Common Shares (187000)	187000	Indirect